Global Clinical Trials ACM Global Laboratories operates in over 65 countries with wholly owned facilities in the U.S., UK, India, and Singapore, indicating strong international reach and capability to support multi-region trials for sponsors seeking global data.

High Throughput Testing With more than 20 million tests annually across pathology, microbiology, molecular diagnostics, and toxicology, ACM offers scalable testing capacity that can accommodate large phase trials and rapid turnaround needs from sponsors.

Therapeutic & Vaccine Focus Historical involvement in COVID-19 vaccine studies and therapeutic development suggests readiness to support vaccine and infectious disease programs, providing end-to-end testing and trial optimization expertise.

Strategic Acquisition The 2017 acquisition of DrugScan expands portfolio and capabilities, signaling a growth-oriented lab network with potential cross-sell opportunities in toxicology, infectious disease, and pharmaceuticals testing services.

Integrated Tech Stack Adoption of cloud and security tools (Azure AD, HashiCorp Terraform, VMware, Cisco Meraki) along with analytics tagging (Piwik PRO) positions ACM for secure, scalable data management and advanced trial analytics, appealing to sponsors prioritizing digitalized operations.